There is no evidence to support federal allegations that a South Carolina community health center illegally diverts 340B-purchased drugs to [...] …
Blog Posts
The future of a Republican drug shortages bill with 340B provisions remains unclear after it was examined in a contentious [...] …
Novo Nordisk will issue refunds to 340B covered entities for some purchases this year of its blockbuster injectable diabetes medication [...] …
The largest health insurer advocacy organization urged federal regulators to reject hospital-sought rules to limit the ability of Medicare Advantage [...] …
A House subcommittee hearing today exposed partisan divisions over the 340B program’s impact on generic drug shortages. The Sep. 14 [...] …
The Louisiana attorney general recently asked a federal district judge to dismiss a drug industry lawsuit that challenges Louisiana’s 340B [...] …
California health centers that participate in the 340B program recently appealed a federal district judge’s dismissal of a suit to reverse [...] …
SPONSORED CONTENT
For over 35 years, Avita Care Solutions’ Chief Medical Officer, Dr. Christopher Hall, has devoted his career to democratizing and scaling compassionate and competent care initiatives to underserved communities—the very patients the 340B program was designed to help. In the following interview, he offers a provider’s point of view on why the drug discount
…
An independent cancer care practice is suing a Philadelphia health system in federal court over a range of alleged anti-competitive [...] …
Two drugmakers owe repayment to 340B covered entities, according to final audits posted this week by federal officials. American Health [...] …